An international study finds that AI surpasses average radiologists in detecting pancreatic cancer on CT scans using a newly developed benchmark and dataset.
Key Details
- 1The study was led by Radboudumc and published in The Lancet Oncology.
- 2A confidential dataset of nearly 400 patient CT scans was assessed by international experts and used to benchmark over 250 submitted AI models.
- 3The best AI model made correct assessments in 92% of scans, compared to 88% for radiologists, and produced 38% fewer false positives.
- 4The AI outperformed the average radiologist but requires further validation before clinical adoption.
- 5The research was funded by the Hanarth Fund and the EU’s Horizon Europe program.
Why It Matters
This study provides strong evidence for the potential of AI to support radiologists in diagnosing pancreatic cancer, a particularly deadly and hard-to-detect disease. The validated benchmark and international collaboration pave the way for further clinical development and adoption of AI in abdominal CT interpretation.
Source
EurekAlert
Related News
•EurekAlert
AI Accelerates Radiopharmaceuticals, Boosts Personalized Dosimetry in Cancer
Machine learning is driving advancements in radiopharmaceutical drug discovery and optimizing patient-specific dosimetry for precision cancer therapy.
•EurekAlert
Physicians Overly Trust Erroneous AI, Ignore Contradictory Evidence
Physicians tend to trust incorrect AI advice, even when evidence contradicts it, suggesting risks in clinical decision-making with AI tools.
•EurekAlert
Concerns Raised Over Unverified Datasets in AI Health Prediction Models
A new study finds widely used AI health prediction models are built on datasets with unverifiable origins, raising safety and validity concerns.